Selected research
Market Structure
Global Complementary DNA Microarrays (cDNA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Complementary DNA Microarrays (cDNA) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Complementary DNA Microarrays (cDNA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Complementary DNA Microarrays (cDNA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Complementary DNA Microarrays (cDNA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Complementary DNA Microarrays (cDNA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Complementary DNA Microarrays (cDNA) include Illumnia, Affymetrix, Agilent, Scienion AG, Applied Microarrays, Arrayit, Sengenics, Biometrix Technology and Savyon Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Complementary DNA Microarrays (cDNA) output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Complementary DNA Microarrays (cDNA) by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Complementary DNA Microarrays (cDNA) market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Complementary DNA Microarrays (cDNA) and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Complementary DNA Microarrays (cDNA) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Complementary DNA Microarrays (cDNA) market size, projected growth trends, production technologies, key applications, and end-use industries.
Complementary DNA Microarrays (cDNA) Segment by Company
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
Complementary DNA Microarrays (cDNA) Segment by Type
Gene expression
Genotyping
Genome cytogenetics
Complementary DNA Microarrays (cDNA) Segment by Application
Oncology
Non-invasive pregnancy testing(NIPT)
Hypertension
diabetes
Nervous system diseases
Other
Complementary DNA Microarrays (cDNA) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Complementary DNA Microarrays (cDNA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Complementary DNA Microarrays (cDNA) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Complementary DNA Microarrays (cDNA).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Complementary DNA Microarrays (cDNA) market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Complementary DNA Microarrays (cDNA) industry.
Chapter 3: Detailed analysis of Complementary DNA Microarrays (cDNA) market competition landscape. Including Complementary DNA Microarrays (cDNA) manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Complementary DNA Microarrays (cDNA) by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Complementary DNA Microarrays (cDNA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene expression
- Genotyping
- Genome cytogenetics
Applications
- Oncology
- Non-invasive pregnancy testing(NIPT)
- Hypertension
- diabetes
- Nervous system diseases
- Other
Companies covered
- Illumnia
- Affymetrix
- Agilent
- Scienion AG
- Applied Microarrays
- Arrayit
- Sengenics
- Biometrix Technology
- Savyon Diagnostics
- WaferGen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Complementary DNA Microarrays (cDNA) Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Complementary DNA Microarrays (cDNA) Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Complementary DNA Microarrays (cDNA) Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Complementary DNA Microarrays (cDNA) Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Complementary DNA Microarrays (cDNA) Market Dynamics
- 2.1 Complementary DNA Microarrays (cDNA) Industry Trends
- 2.2 Complementary DNA Microarrays (cDNA) Industry Drivers
- 2.3 Complementary DNA Microarrays (cDNA) Industry Opportunities and Challenges
- 2.4 Complementary DNA Microarrays (cDNA) Industry Restraints
3 Complementary DNA Microarrays (cDNA) Market by Manufacturers
- 3.1 Global Complementary DNA Microarrays (cDNA) Production Value by Manufacturers (2021-2026)
- 3.2 Global Complementary DNA Microarrays (cDNA) Production by Manufacturers (2021-2026)
- 3.3 Global Complementary DNA Microarrays (cDNA) Average Price by Manufacturers (2021-2026)
- 3.4 Global Complementary DNA Microarrays (cDNA) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Complementary DNA Microarrays (cDNA) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Complementary DNA Microarrays (cDNA) Manufacturers, Product Type & Application
- 3.7 Global Complementary DNA Microarrays (cDNA) Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Complementary DNA Microarrays (cDNA) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Complementary DNA Microarrays (cDNA) Players Market Share by Production Value in 2025
- 3.8.3 2025 Complementary DNA Microarrays (cDNA) Tier 1, Tier 2, and Tier 3
4 Complementary DNA Microarrays (cDNA) Market by Type
- 4.1 Complementary DNA Microarrays (cDNA) Type Introduction
- 4.1.1 Gene expression
- 4.1.2 Genotyping
- 4.1.3 Genome cytogenetics
- 4.2 Global Complementary DNA Microarrays (cDNA) Production by Type
- 4.2.1 Global Complementary DNA Microarrays (cDNA) Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Complementary DNA Microarrays (cDNA) Production by Type (2021-2032)
- 4.2.3 Global Complementary DNA Microarrays (cDNA) Production Market Share by Type (2021-2032)
- 4.3 Global Complementary DNA Microarrays (cDNA) Production Value by Type
- 4.3.1 Global Complementary DNA Microarrays (cDNA) Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Complementary DNA Microarrays (cDNA) Production Value by Type (2021-2032)
- 4.3.3 Global Complementary DNA Microarrays (cDNA) Production Value Market Share by Type (2021-2032)
5 Complementary DNA Microarrays (cDNA) Market by Application
- 5.1 Complementary DNA Microarrays (cDNA) Application Introduction
- 5.1.1 Oncology
- 5.1.2 Non-invasive pregnancy testing(NIPT)
- 5.1.3 Hypertension
- 5.1.4 diabetes
- 5.1.5 Nervous system diseases
- 5.1.6 Other
- 5.2 Global Complementary DNA Microarrays (cDNA) Production by Application
- 5.2.1 Global Complementary DNA Microarrays (cDNA) Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Complementary DNA Microarrays (cDNA) Production by Application (2021-2032)
- 5.2.3 Global Complementary DNA Microarrays (cDNA) Production Market Share by Application (2021-2032)
- 5.3 Global Complementary DNA Microarrays (cDNA) Production Value by Application
- 5.3.1 Global Complementary DNA Microarrays (cDNA) Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Complementary DNA Microarrays (cDNA) Production Value by Application (2021-2032)
- 5.3.3 Global Complementary DNA Microarrays (cDNA) Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Illumnia
- 6.1.1 Illumnia Company Information
- 6.1.2 Illumnia Business Overview
- 6.1.3 Illumnia Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 6.1.4 Illumnia Complementary DNA Microarrays (cDNA) Product Portfolio
- 6.1.5 Illumnia Recent Developments
- 6.2 Affymetrix
- 6.2.1 Affymetrix Company Information
- 6.2.2 Affymetrix Business Overview
- 6.2.3 Affymetrix Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 6.2.4 Affymetrix Complementary DNA Microarrays (cDNA) Product Portfolio
- 6.2.5 Affymetrix Recent Developments
- 6.3 Agilent
- 6.3.1 Agilent Company Information
- 6.3.2 Agilent Business Overview
- 6.3.3 Agilent Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 6.3.4 Agilent Complementary DNA Microarrays (cDNA) Product Portfolio
- 6.3.5 Agilent Recent Developments
- 6.4 Scienion AG
- 6.4.1 Scienion AG Company Information
- 6.4.2 Scienion AG Business Overview
- 6.4.3 Scienion AG Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 6.4.4 Scienion AG Complementary DNA Microarrays (cDNA) Product Portfolio
- 6.4.5 Scienion AG Recent Developments
- 6.5 Applied Microarrays
- 6.5.1 Applied Microarrays Company Information
- 6.5.2 Applied Microarrays Business Overview
- 6.5.3 Applied Microarrays Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 6.5.4 Applied Microarrays Complementary DNA Microarrays (cDNA) Product Portfolio
- 6.5.5 Applied Microarrays Recent Developments
- 6.6 Arrayit
- 6.6.1 Arrayit Company Information
- 6.6.2 Arrayit Business Overview
- 6.6.3 Arrayit Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 6.6.4 Arrayit Complementary DNA Microarrays (cDNA) Product Portfolio
- 6.6.5 Arrayit Recent Developments
- 6.7 Sengenics
- 6.7.1 Sengenics Company Information
- 6.7.2 Sengenics Business Overview
- 6.7.3 Sengenics Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 6.7.4 Sengenics Complementary DNA Microarrays (cDNA) Product Portfolio
- 6.7.5 Sengenics Recent Developments
- 6.8 Biometrix Technology
- 6.8.1 Biometrix Technology Company Information
- 6.8.2 Biometrix Technology Business Overview
- 6.8.3 Biometrix Technology Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 6.8.4 Biometrix Technology Complementary DNA Microarrays (cDNA) Product Portfolio
- 6.8.5 Biometrix Technology Recent Developments
- 6.9 Savyon Diagnostics
- 6.9.1 Savyon Diagnostics Company Information
- 6.9.2 Savyon Diagnostics Business Overview
- 6.9.3 Savyon Diagnostics Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 6.9.4 Savyon Diagnostics Complementary DNA Microarrays (cDNA) Product Portfolio
- 6.9.5 Savyon Diagnostics Recent Developments
- 6.10 WaferGen
- 6.10.1 WaferGen Company Information
- 6.10.2 WaferGen Business Overview
- 6.10.3 WaferGen Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 6.10.4 WaferGen Complementary DNA Microarrays (cDNA) Product Portfolio
- 6.10.5 WaferGen Recent Developments
7 Global Complementary DNA Microarrays (cDNA) Production by Region
- 7.1 Global Complementary DNA Microarrays (cDNA) Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Complementary DNA Microarrays (cDNA) Production by Region (2021-2032)
- 7.2.1 Global Complementary DNA Microarrays (cDNA) Production by Region (2021-2026)
- 7.2.2 Global Complementary DNA Microarrays (cDNA) Production Forecast by Region (2027-2032)
- 7.3 Global Complementary DNA Microarrays (cDNA) Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Complementary DNA Microarrays (cDNA) Production Value by Region (2021-2032)
- 7.4.1 Global Complementary DNA Microarrays (cDNA) Production Value by Region (2021-2026)
- 7.4.2 Global Complementary DNA Microarrays (cDNA) Production Value by Region (2027-2032)
- 7.5 Global Complementary DNA Microarrays (cDNA) Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Complementary DNA Microarrays (cDNA) Production Value (2021-2032)
- 7.6.2 Europe Complementary DNA Microarrays (cDNA) Production Value (2021-2032)
- 7.6.3 Asia-Pacific Complementary DNA Microarrays (cDNA) Production Value (2021-2032)
- 7.6.4 South America Complementary DNA Microarrays (cDNA) Production Value (2021-2032)
- 7.6.5 Middle East & Africa Complementary DNA Microarrays (cDNA) Production Value (2021-2032)
8 Global Complementary DNA Microarrays (cDNA) Consumption by Region
- 8.1 Global Complementary DNA Microarrays (cDNA) Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Complementary DNA Microarrays (cDNA) Consumption by Region (2021-2032)
- 8.2.1 Global Complementary DNA Microarrays (cDNA) Consumption by Region (2021-2026)
- 8.2.2 Global Complementary DNA Microarrays (cDNA) Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Complementary DNA Microarrays (cDNA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Complementary DNA Microarrays (cDNA) Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Complementary DNA Microarrays (cDNA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Complementary DNA Microarrays (cDNA) Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Complementary DNA Microarrays (cDNA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Complementary DNA Microarrays (cDNA) Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Complementary DNA Microarrays (cDNA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Complementary DNA Microarrays (cDNA) Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Complementary DNA Microarrays (cDNA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Complementary DNA Microarrays (cDNA) Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Complementary DNA Microarrays (cDNA) Value Chain Analysis
- 9.1.1 Complementary DNA Microarrays (cDNA) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Complementary DNA Microarrays (cDNA) Production Mode & Process
- 9.2 Complementary DNA Microarrays (cDNA) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Complementary DNA Microarrays (cDNA) Distributors
- 9.2.3 Complementary DNA Microarrays (cDNA) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst